Fortis Malar Hospitals Ltd.
Snapshot View

53.60 -0.40 ▼-0.7%

27 June 2022, 04:01:00 PM
Volume: 879

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.fortismalar.com
Market Cap 100.46 Cr.
Enterprise Value(EV) 87.90 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -4.41 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 39.15 Trailing Twelve Months Ending 2022-03
Book Value / Share 42.75 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.25 Calculated using Price: 53.60
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.87 Cr. 18,741,759 Shares
FaceValue 10
Company Profile
Malar Hospitals (an Associate of Fortis Healthcare), like every other Fortis hospital, is a manifestation of the founder's vision of creating a world-class integrated healthcare delivery system in India, entailing the finest medical skills combined with compassionate patient care.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-0.74%
1 Week
-0.65%
1 Month
+1.04%
3 Month
-7.19%
6 Month
-12.92%
1 Year
-19.28%
2 Year
+1.61%
5 Year
-26.42%
10 Year
+106.95%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 78.53 10.84 8.93 6.80 3.16 3.28 1.97 -8.82 -8.50
Return on Capital Employed (%) 97.46 17.10 14.17 10.96 5.00 5.90 3.17 -4.09 -4.44
Return on Assets (%) 41.57 9.13 6.85 4.97 2.40 2.40 1.39 -5.27 -4.51

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 77 85 91 98 100 103 105 96 89 80
Non Curr. Liab. 1 1 0 0 0 0 0 56 47 41
Curr. Liab. 13 16 37 32 30 45 44 36 25 31
Minority Int.
Equity & Liab. 91 101 128 130 130 148 149 188 161 152
Non Curr. Assets 18 20 20 28 33 34 37 126 101 103
Curr. Assets 73 82 108 102 97 113 112 62 60 49
Misc. Exp. not W/O
Total Assets 91 101 128 130 130 148 149 188 161 152

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 98 108 118 130 141 149 145 112 69 86
Other Income 5 7 8 9 8 8 10 11 8 7
Total Income 102 115 126 138 149 158 155 123 78 94
Total Expenditure -86 -99 -110 -124 -140 -147 -147 -115 -76 -83
PBIDT 16 16 15 14 9 10 8 8 2 11
Interest -1 0 -1 0 0 0 -1 -8 -7 -7
Depreciation -2 -2 -3 -3 -4 -4 -4 -13 -13 -13
Taxation -13 -5 -4 -4 -1 -2 -1 3 3 0
Exceptional Items 44 -1 7
PAT 43 9 8 6 3 3 2 -9 -8 -8
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 43 9 8 6 3 3 2 -9 -8 -8
Adjusted EPS 23 5 4 3 2 2 1 -5 -4 -4

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 11 -64 5 4 10 -9 9 -16 0 -1
Cash Fr. Inv. -10 73 -1 5 -22 13 -2 6 50 -28
Cash Fr. Finan. -1 -7 -1 -1 -1 0 0 -12 -7
Net Change 0 2 3 10 -13 4 7 -9 38 -36
Cash & Cash Eqvt 1 3 6 16 3 7 15 5 43 7

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 62.71 62.71 62.71 62.71 62.71 62.71 62.71 62.71 62.71
Public 37.29 37.29 37.29 37.29 37.29 37.29 37.29 37.29 37.29
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Mon, 27 Jun 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 read with circular no. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR / 2022 / 8 dated January 25 2022 we would like to inform you that the Company has issued letter of confirmation in lieu of physical duplicate share certificate for the original share certificate reported lost/misplaced.You are requested to take the same on your record.
Thu, 23 Jun 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith copies of newspaper advertisement published in the columns of English daily Financial Express on June 23 2022 and Punjabi daily Rozana Spokesman Mohali edition in terms of General Circular Nos.14/2020 17/2020 20/2020 21/2021 and 03/2022 dated 8th April 2020 13th April 2020 5th May 2020 14th December 2021 and 5th May 2022 respectively issued by the Ministry of Corporate Affairs inter-alia intimating that 31st AGM of the Company will be held on Wednesday July 27 2022 through VC/OAVM facility. You are requested to take the same on your record.
Wed, 22 Jun 2022
Intimation Of Annual General Meeting ('31St AGM') And Cut-Off Date For The Purpose Of 31St AGM.
This is to inform that 31st AGM of the Company will be convened on Wednesday 27th July 2022 through VC/ OAVM facility in compliance with the applicable provisions of the Companies Act 2013 Rules framed thereunder and the SEBI LODR read with General Circulars issued by MCA and SEBI .The Company has fixed Friday 24th June 2022 as the cut-off date to determine the eligibility of shareholders to whom notice of 31st AGM and Annual Report will be sent.In terms of Section 108 of the Companies Act 2013 and Rule 20 of the Companies (Management & Administration) Rules 2014 (as amended) has fixed Wednesday 20th July 2022 as the cut-off date to determine the eligibility of the members to cast their vote by electronic means and e-Voting during31st AGM.You are requested to take the same on your record.

Technical Scans View Details

Mon, 27 Jun 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. 48,438.53 2,858.25 -0.6%
Gland Pharma Ltd. 43,775.42 2,658.60 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.24 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 36.13 2,658.60 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.12 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 6.12 2,658.60 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,658.60 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,658.60 +0.6%

FAQ's On Fortis Malar Hospitals Ltd.

Can I Buy Fortis MalarHospital Shares now?

What is the Share Price of Fortis MalarHospital?

What is the Relative Strength Index (RSI) Value of Fortis MalarHospital?

What is the Market Capital (MCAP) of Fortis MalarHospital?

What are the key metrics to analyse Fortis MalarHospital?

What is the Price Performance of Fortis MalarHospital?